Product Code: ETC13375649 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Transarterial Chemoembolization Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Transarterial Chemoembolization Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Transarterial Chemoembolization Market Revenues & Volume, 2021 & 2031F |
3.3 North America Transarterial Chemoembolization Market - Industry Life Cycle |
3.4 North America Transarterial Chemoembolization Market - Porter's Five Forces |
3.5 North America Transarterial Chemoembolization Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Transarterial Chemoembolization Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 North America Transarterial Chemoembolization Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 North America Transarterial Chemoembolization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America Transarterial Chemoembolization Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Transarterial Chemoembolization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Transarterial Chemoembolization Market Trends |
6 North America Transarterial Chemoembolization Market, 2021 - 2031 |
6.1 North America Transarterial Chemoembolization Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Conventional TACE (cTACE), 2021 - 2031 |
6.1.3 North America Transarterial Chemoembolization Market, Revenues & Volume, By Drug-Eluting Bead TACE (DEB-TACE), 2021 - 2031 |
6.1.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Procedure, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Catheter-Based Drug Delivery, 2021 - 2031 |
6.2.3 North America Transarterial Chemoembolization Market, Revenues & Volume, By Microsphere-Based Therapy, 2021 - 2031 |
6.2.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By AI-Guided Embolization, 2021 - 2031 |
6.3 North America Transarterial Chemoembolization Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Liver Cancer Treatment, 2021 - 2031 |
6.3.3 North America Transarterial Chemoembolization Market, Revenues & Volume, By Hepatocellular Carcinoma, 2021 - 2031 |
6.3.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By Metastatic Tumors, 2021 - 2031 |
6.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Transarterial Chemoembolization Market, Revenues & Volume, By Oncology Centers, 2021 - 2031 |
6.4.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
7 North America Transarterial Chemoembolization Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Transarterial Chemoembolization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United States (US) Transarterial Chemoembolization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Canada Transarterial Chemoembolization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Rest of North America Transarterial Chemoembolization Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 North America Transarterial Chemoembolization Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
7.3.1 United States (US) Transarterial Chemoembolization Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.2 Canada Transarterial Chemoembolization Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.3.3 Rest of North America Transarterial Chemoembolization Market, Revenues & Volume, By Procedure, 2021 - 2031 |
7.4 North America Transarterial Chemoembolization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) Transarterial Chemoembolization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada Transarterial Chemoembolization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America Transarterial Chemoembolization Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Transarterial Chemoembolization Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Transarterial Chemoembolization Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Transarterial Chemoembolization Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Transarterial Chemoembolization Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Transarterial Chemoembolization Market Key Performance Indicators |
9 North America Transarterial Chemoembolization Market - Export/Import By Countries Assessment |
10 North America Transarterial Chemoembolization Market - Opportunity Assessment |
10.1 North America Transarterial Chemoembolization Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Transarterial Chemoembolization Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 North America Transarterial Chemoembolization Market Opportunity Assessment, By Procedure, 2021 & 2031F |
10.4 North America Transarterial Chemoembolization Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America Transarterial Chemoembolization Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Transarterial Chemoembolization Market - Competitive Landscape |
11.1 North America Transarterial Chemoembolization Market Revenue Share, By Companies, 2022 |
11.2 North America Transarterial Chemoembolization Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |